Disparities in HPV vaccine knowledge and adolescent HPV vaccine uptake by parental nativity among diverse multiethnic parents in New Jersey.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
29 01 2022
Historique:
received: 18 10 2021
accepted: 11 01 2022
entrez: 30 1 2022
pubmed: 31 1 2022
medline: 19 4 2022
Statut: epublish

Résumé

Suboptimal human papillomavirus (HPV) vaccination rates persist among adolescents in the United States (U.S.). New Jersey (NJ), among the top, most racially/ethnically diverse states in the U.S., had among the lowest HPV vaccine initiation rates, prior to 2018. This study examined parental HPV vaccine knowledge and adolescent HPV vaccine initiation among multiethnic parents in NJ, where access to language concordant HPV vaccine information and vaccination services may differ, for immigrant parents. We surveyed parents of adolescents (ages 11-18) at community events in NJ to examine parental HPV vaccine knowledge and adolescent HPV vaccine uptake. Vaccine knowledge was assessed using an 11-item question stem that covered vaccine efficacy, gender recommendation, vaccine protection, and myths. Multivariable models assessed the association of parent nativity on HPV vaccine knowledge scores and adolescent HPV vaccine initiation, controlling for sociodemographic factors. Of the 77 parents, most parents (84%) were aware of the HPV vaccine. However, knowledge scores were low and differed by parent nativity. Non-U.S. born parents had significantly lower knowledge scores - 1.7 [- 3.1, - 0.4] and lower odds of adolescent children initiating the HPV vaccine 0.3 [0.1, 0.9] compared to U.S.-born parents after adjusting demographic characteristics. Our findings reveal that parental HPV vaccine knowledge remains low among suburban dwelling, immigrant parents, even though they have higher education and access to health care. Multilevel strategies to reduce missed opportunities for HPV vaccine education among parents and HPV vaccination for adolescents are needed, including for suburban, immigrant communities.

Sections du résumé

BACKGROUND
Suboptimal human papillomavirus (HPV) vaccination rates persist among adolescents in the United States (U.S.). New Jersey (NJ), among the top, most racially/ethnically diverse states in the U.S., had among the lowest HPV vaccine initiation rates, prior to 2018. This study examined parental HPV vaccine knowledge and adolescent HPV vaccine initiation among multiethnic parents in NJ, where access to language concordant HPV vaccine information and vaccination services may differ, for immigrant parents.
METHODS
We surveyed parents of adolescents (ages 11-18) at community events in NJ to examine parental HPV vaccine knowledge and adolescent HPV vaccine uptake. Vaccine knowledge was assessed using an 11-item question stem that covered vaccine efficacy, gender recommendation, vaccine protection, and myths. Multivariable models assessed the association of parent nativity on HPV vaccine knowledge scores and adolescent HPV vaccine initiation, controlling for sociodemographic factors.
RESULTS
Of the 77 parents, most parents (84%) were aware of the HPV vaccine. However, knowledge scores were low and differed by parent nativity. Non-U.S. born parents had significantly lower knowledge scores - 1.7 [- 3.1, - 0.4] and lower odds of adolescent children initiating the HPV vaccine 0.3 [0.1, 0.9] compared to U.S.-born parents after adjusting demographic characteristics.
CONCLUSIONS
Our findings reveal that parental HPV vaccine knowledge remains low among suburban dwelling, immigrant parents, even though they have higher education and access to health care. Multilevel strategies to reduce missed opportunities for HPV vaccine education among parents and HPV vaccination for adolescents are needed, including for suburban, immigrant communities.

Identifiants

pubmed: 35093050
doi: 10.1186/s12889-022-12573-7
pii: 10.1186/s12889-022-12573-7
pmc: PMC8800253
doi:

Substances chimiques

Papillomavirus Vaccines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

195

Informations de copyright

© 2022. The Author(s).

Références

MMWR Morb Mortal Wkly Rep. 2019 Aug 23;68(33):718-723
pubmed: 31437143
Hum Vaccin Immunother. 2021 Jul 3;17(7):1961-1967
pubmed: 33439768
JAMA Pediatr. 2014 Jan;168(1):76-82
pubmed: 24276343
Health Aff (Millwood). 2017 Oct 1;36(10):1777-1785
pubmed: 28971923
MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1109-1116
pubmed: 32817598
J Immigr Minor Health. 2016 Oct;18(5):1060-1065
pubmed: 26001843
Hum Vaccin Immunother. 2019;15(7-8):1897-1903
pubmed: 30735451
Vaccine. 2015 Jan 3;33(2):289-93
pubmed: 25434792
Am J Health Behav. 2019 Sep 1;43(5):994-1005
pubmed: 31439104
Hum Vaccin Immunother. 2019;15(7-8):1784-1793
pubmed: 30779687
Trop Med Infect Dis. 2020 Apr 09;5(2):
pubmed: 32283644
MMWR Morb Mortal Wkly Rep. 2018 Aug 24;67(33):909-917
pubmed: 30138305
J Womens Health (Larchmt). 2019 Jun;28(6):747-751
pubmed: 31107143
Hum Vaccin Immunother. 2021 Apr 3;17(4):1083-1088
pubmed: 33326347
Clin Pediatr (Phila). 2015 Sep;54(10):987-91
pubmed: 26045587
J Natl Cancer Inst Monogr. 2012 May;2012(44):2-10
pubmed: 22623590
Prev Med. 2013 Jan;56(1):35-40
pubmed: 23142106
Front Public Health. 2021 May 28;9:674035
pubmed: 34123992
Appl Nurs Res. 2018 Dec;44:54-59
pubmed: 30389060
Cancer Causes Control. 2017 Nov;28(11):1341-1347
pubmed: 29098504
Public Health Rep. 2011 Jul-Aug;126 Suppl 2:60-9
pubmed: 21812170
Ethn Health. 2020 Oct;25(7):982-994
pubmed: 29745749
Health Equity. 2018 Sep 01;2(1):223-232
pubmed: 30283871
J Infect Dis. 2018 Nov 5;218(12):1900-1910
pubmed: 30010913
Vaccine. 2017 Oct 9;35(42):5700-5707
pubmed: 28893472
Soc Sci Med. 2016 Jun;159:116-26
pubmed: 27180256
Vaccine. 2012 May 21;30(24):3546-56
pubmed: 22480928
Prev Med. 2020 Feb;131:105968
pubmed: 31881235

Auteurs

Bianca Anuforo (B)

Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.

Jennifer K McGee-Avila (JK)

School of Nursing, Rutgers, The State University of New Jersey, Newark, NJ, USA.

Lindsey Toler (L)

School of Public Health, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.

Baichen Xu (B)

Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.

Racquel E Kohler (RE)

Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.

Sharon Manne (S)

Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.

Jennifer Tsui (J)

Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, 1441 Eastlake Ave, Los Angeles, CA, 90033, USA. tsuijenn@usc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH